Cohort 3 summary statistics.
| Never | Remission | Relapse | ||
|---|---|---|---|---|
| Number of women (n) | 26 | 35 | 31 | |
| Hx of fulguration | 0 | 20 | 19 | |
| Median Age (IQR) (yr) | 69.5 (63–77.75) | 70 (63–81) | 74 (70–80) | |
| Median BMI (IQR) (kg/m2) | 26.05 (21.4–27.5) | 27.8 (22–31) | 27.9 (25.4–32.1) | |
| Median urine pH (IQR) | 6 (5–7) | 5.82 (5–6.74) | 5.35 (5–6) | |
| AODM (%) | 1 (3%) | 7 (20%) | 6 (19.35%) | |
| EHT (%) | 14 (53%) | 22 (62%) | 9 (29%) | |
| NSAID | Selective (%) | 2 (7.69%) | 5 (14.28%) | 1 (3.22%) |
| Nonselective (%) | 6 (23.07%) | 7 (20%) | 2 (6.45%) | |
Median and interquartile range (IQR) for age; (BMI) body mass index, and urinary pH. AODM, adult-onset diabetes mellitus; EHT, estrogen hormone therapy; NSAID, nonsteroidal anti-inflammatory drugs.